An implantable artificial kidney could transform prospects for people whose kidneys have failed and who have to rely on dialysis or the rare chance of a transplant to stay alive. Now, researchers working on the first-of-its-kind device that aims to meet this need says they are hopeful of running pilot trials in humans within the year
For the first time, scientists have created vocal cord tissue starting with cells from human vocal cords. When tested in the lab, the bioengineered tissue vibrated—and even sounded—similar to the natural thing. The development could one day help those with severely damaged vocal cords regain their lost voices.
Scientists have developed a new, highly sensitive chemical probe that tags cells for detection by magnetic resonance imaging. The discovery, which could contribute to both research and the development of future therapies, is described in Nature Materials.
A new study describes a pioneering new cataract treatment – tested in animals and in a small trial with human patients – where, after the cloudy lens is removed, the eye grows a new lens from its own stem cells.
A lack of stem cells in the womb lining could be the reason behind thousands of miscarriages, says research published in the journal Stem Cells that could offer new hope of treatment for women who repeatedly experience failed pregnancy.
Functioning sperm that could one day be used to treat infertility in men have been created in a laboratory by scientists in China, according to a report in Cell Stem Cell.
A new study led by scientists at The Scripps Research Institute (TSRI) and the J. Craig Venter Institute (JCVI) shows that the act of creating pluripotent stem cells for clinical use is unlikely to pass on cancer-causing mutations to patients.
In what has been hailed a breakthrough in regenerative medicine, scientists have developed functional ear, bone and muscle structures using 3D-bioprinting technology.
An adult kidney has been transplanted into a child with the help of 3D printing techniques, says a report from Guy’s and St Thomas’ in London, UK.
New research shows that by encapsulating them in a new biomaterial, implanted human pancreatic cells can withstand attack by the immune system in mice for up to 6 months, while maintaining their ability to sense low blood sugar and produce insulin in response.